Skip to content
Atlas Bid Management
All tender opportunities

Opportunity brief

Closed

WBS-FTS-64245 Haematology Testing System

The Welsh Blood Service (WBS) requires an advanced automated haematology analysis system to support blood donor assessment, blood component quality monitoring, research and innovation activities. The proposed solution will be required to provide automated full blood count (FBC) analysis, 5-part white cell differential capability and integrated reticulocyte analysis on the primary analyser. Of particular interest are systems capable of generating the data required to support emerging donor health assessment methodologies, including FlowScore calculation and reticulated haemoglobin analysis for the early detection of iron deficiency in blood donors. The requirement is includes advanced analytical capabilities that support the unique operational needs of a blood establishment. These include fluorescence platelet counting with high accuracy at low platelet concentrations, reticulated platelet measurement, low-level white cell enumeration suitable for blood component quality monitoring, and the ability to perform blood component testing without the need for separate instrumentation. Suppliers should be able to demonstrate how their platforms support routine blood component quality control programmes through dedicated blood bank functionality and provide evidence of successful implementation within blood services, blood centres or comparable blood establishments. WBS is particularly interested in solutions that are supported by robust External Quality Assessment (EQA/EQAS) programmes and can demonstrate meaningful peer group benchmarking through sufficient participant numbers using the same analyser platform and methodology. Suppliers should be able to demonstrate compliance with applicable medical device regulations, support quality and regulatory requirements through a mature quality management system and provide resilient service and maintenance arrangements that minimise downtime and ensure continuity of critical testing services.

  • Other sectors
  • Public sector
  • United Kingdom
Buyer / issuer
Velindre University NHS Trust
Sector
Other sectors
Country / region
United Kingdom
Public or private
Public sector
Closing date
04 Nov 2026, 14:00 SAST
Estimated value
£409k
GBP
Submission method
Via the buyer's portal, linked from Find a Tender
Tender number
WBS-FTS-64245
Status
Closed

Scope summary

The Welsh Blood Service (WBS) requires an advanced automated haematology analysis system to support blood donor assessment, blood component quality monitoring, research and innovation activities. The proposed solution will be required to provide automated full blood count (FBC) analysis, 5-part white cell differential capability and integrated reticulocyte analysis on the primary analyser. Of particular interest are systems capable of generating the data required to support emerging donor health assessment methodologies, including FlowScore calculation and reticulated haemoglobin analysis for the early detection of iron deficiency in blood donors. The requirement is includes advanced analytical capabilities that support the unique operational needs of a blood establishment. These include fluorescence platelet counting with high accuracy at low platelet concentrations, reticulated platelet measurement, low-level white cell enumeration suitable for blood component quality monitoring, and the ability to perform blood component testing without the need for separate instrumentation. Suppliers should be able to demonstrate how their platforms support routine blood component quality control programmes through dedicated blood bank functionality and provide evidence of successful implementation within blood services, blood centres or comparable blood establishments. WBS is particularly interested in solutions that are supported by robust External Quality Assessment (EQA/EQAS) programmes and can demonstrate meaningful peer group benchmarking through sufficient participant numbers using the same analyser platform and methodology. Suppliers should be able to demonstrate compliance with applicable medical device regulations, support quality and regulatory requirements through a mature quality management system and provide resilient service and maintenance arrangements that minimise downtime and ensure continuity of critical testing services.

Category: goods

Key requirements

  • Procurement method: Open procedure
  • Briefing session: Not captured. Check the original notice before relying on this.
  • Eligibility and evaluation: set out in the tender documents. Check mandatory returnables, registrations and scoring before you commit.

Required documents

Important dates

Published
06 Oct 2026
First seen by Atlas
07 Oct 2026
Briefing session
Not captured. Check the original notice before relying on this.
Submission deadline
04 Nov 2026, 14:00 SAST

Commercial snapshot

Estimated value
£409k
Contract type
Open procedure
Category
goods
Source
UK Find a Tender

Live data from Atlas Tender Intelligence, gathered from official procurement portals and refreshed daily. Always confirm details on the original notice.